Prestige Consumer Healthcare Inc. (NYSE: PBH) is a Healthcare company (Medical - Pharmaceuticals) with a market capitalization of $2.3B. The Maz Rating grades it against the other companies in its sector.
Prestige Consumer Healthcare Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $48.22, Prestige Consumer Healthcare Inc. trades at 14.9x trailing earnings, 2.0x sales and 1.2x book value, with an EV/EBITDA of 13.8. Over the last twelve months it generated about $1.2B of revenue and $154M of net income. It runs a gross margin of 52.0%, an operating margin of 25.0% and a net margin of 13.3%. It shows return on equity of 8.2%, return on invested capital of 4.7% and a free cash flow yield of 9.4%. On the balance sheet: a debt-to-equity ratio of 1.09 and a current ratio of 2.92. Over the past 52 weeks the share price ranged from $41.77 to $71.07, with a beta of 0.34.
Prestige Consumer Healthcare Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 11 Buy, 4 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.